Latest KFF Health News Stories
Psychoactive Drugs Are Having a Moment. The FDA Will Soon Weigh In.
Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.
FDA Urged To Relax Decades-Old Tissue Donation Restrictions for Gay and Bisexual Men
Federal regulations prevent gay and bisexual men from donating tissue, such as corneas, ligaments, and blood vessels. Similar restrictions have been relaxed or lifted for donated blood and organs in recent years.
Reclaman revisar viejas restricciones que previenen que hombres gay y bisexuales donen tejidos
Defensores piden que las pautas para los tejidos donados por hombres gays y bisexuales sean las mismas que aplican al resto del cuerpo humano.
FDA Said It Never Inspected Dental Lab That Made Controversial AGGA Device
Johns Dental Laboratories stopped making the Anterior Growth Guidance Appliance last year after a KFF Health News-CBS News investigation into allegations of patient harm. The company had “never” reported any complaints about its products to the FDA, according to the agency.
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.
What’s Keeping the US From Allowing Better Sunscreens?
A decade after Congress told the FDA to expedite the approval of more effective sunscreens, the federal government still has not approved sunscreen ingredients that are safely being used around the world. Meanwhile, skin cancer is the nation’s most common cancer.
Las pruebas han detectado el virus en el ganado en nueve estados, principalmente en Texas y Nuevo México, y más recientemente en Colorado. Una persona ha dado positivo para el H5N1.
Bird Flu Is Bad for Poultry and Dairy Cows. It’s Not a Dire Threat for Most of Us — Yet.
Cattle across the country are infected by the H5N1 bird flu. The virus isn’t spreading among people — but if it evolves to do that, fears of another pandemic could be realized.
KFF Health News' 'What the Health?': Abortion Access Changing Again in Florida and Arizona
A six-week abortion ban took effect in Florida this week, dramatically restricting access to the procedure not just in the nation’s third-most-populous state but across the South. Patients from states with even more restrictive bans had been flooding in since the overturn of Roe v. Wade in 2022. Meanwhile, the CEO of the health behemoth UnitedHealth Group appeared before committees in both the House and Senate, where lawmakers grilled him about the February cyberattack on subsidiary Change Healthcare and how its ramifications are being felt months later. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of KFF Health News join KFF Health News’ Julie Rovner to discuss these stories and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
FDA Announces Recall of Heart Pumps Linked to Deaths and Injuries
Some pumps used in end-stage heart failure caused a buildup of biological material that blocks blood flow from the device to the heart’s aorta. The FDA’s recall affects nearly 14,000 devices.
Ten Doctors on FDA Panel Reviewing Abbott Heart Device Had Financial Ties With Company
Most of the doctors the FDA tapped to advise it on an Abbott medical device had financial ties to the company. The FDA didn’t disclose the payments.
At Stake in Mifepristone Case: Abortion, FDA’s Authority, and Return to 1873 Obscenity Law
The end goal for a conservative Christian group’s mifepristone case before the Supreme Court: a de facto nationwide abortion ban.
Ya hay una droga oral para la depresión postparto… pero cuesta $16,000
Abogados, defensores y reguladores están observando de cerca cómo las aseguradoras diseñarán las normas para cubrirlo.
A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?
A pill form of an effective drug for postpartum depression hit the market in December, but most insurers do not yet have a policy on when or whether they will pay for it. The hurdles to obtain its predecessor medication have advocates worried.
Colorado Isn’t Giving up on Its Drug Importation Dream
Colorado hopes to join Florida to become only the second state authorized to import prescription drugs from Canada. But they’re hitting the same hurdles: drugmakers — and the FDA. Colorado officials recently amended their 2022 importation application with the Food and Drug Administration, in the process revealing new correspondence that shows the state’s so-far fruitless […]
Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Update
The Environmental Protection Agency is tightening regulation of ethylene oxide, a carcinogenic gas used to sterilize medical devices. The agency is trying to balance the interests of the health care industry supply chain with those of communities where the gas creates airborne health risks.
Washington intenta ponerse al día con el uso de la inteligencia artificial en el sector de salud
El impacto de la IA en el sector de salud ya es generalizado. La Administración de Alimentos y Medicamentos ha aprobado unos 692 productos de inteligencia artificial.
‘Behind the Times’: Washington Tries to Catch Up With AI’s Use in Health Care
Lawmakers and regulators are trying to understand how AI is changing health care and how it should be regulated. The industry fears overreach.
La FDA finalmente prohibiría peligroso químico en productos para alisar el cabello
El primer estudio que vinculó los alisadores de cabello con el cáncer de útero, publicado en 2022, encontró que el uso frecuente de estos químicos duplica con creces el peligro.
FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
